Dr Florian Markowetz awarded a CRUK Future Leaders Prize
Dr Florian Markowetz was one of three researchers awarded a Cancer Research UK Future Leaders in Cancer Research Prize at an awards ceremony at the National Cancer Research Institute (NCRI) Cancer Conference.
This prize recognises scientists early in their career whose significant contribution to cancer research demonstrates their potential to become world-class leaders in their field.
Dr Florian Markowetz’s work is providing insights into how tumours interact with their environment. By studying the cancer’s genes in the context of the tissue around it, they are finding which signals indicate how a cancer will behave. You can find out more about his work here.
Sir Harpal Kumar, chief executive of Cancer Research UK, said: “I’m delighted to announce this year’s prize winners. These pioneering scientists are receiving awards for their extraordinary and wide-ranging contributions to cancer research. Although their work spans many different areas and types of cancer, they all share a determination to beat cancer for good. Through their pioneering work they open up new opportunities to detect and treat cancer which will help us save lives.”
Related News
See all news-
New immune pathway offers treatment hope for childhood brain tumours
3rd February 2026
A newly discovered immune pathway could lead to gentler treatments for multiple childhood brain cancers, according to new research from our Gilbertson Group published today in Nature Genetics.
Find out more -
Targeting paused cells could improve chemotherapy for lung and ovarian cancers
3rd February 2026
New research published today in Nature Aging by scientists at the University of Cambridge sheds light on why some lung and ovarian cancers stop responding to chemotherapy, and how this resistance might one day be prevented.
Find out more -
Hot flush treatment has anti-breast cancer activity, study finds
5th January 2026
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.
Find out more